
Adagene ADAG
$ 3.64
-1.49%
Annual report 2025
added 04-25-2026
Adagene Cash Conversion Cycle 2011-2026 | ADAG
Annual Cash Conversion Cycle Adagene
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 53.8 | 125 | 182 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 182 | 53.8 | 120 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amphastar Pharmaceuticals
AMPH
|
205 | $ 21.77 | 1.68 % | $ 1.02 B | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-400 | $ 0.92 | 3.05 % | $ 6.76 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
257 | $ 22.44 | 2.16 % | $ 3.72 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 2.02 | 5.76 % | $ 420 M | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Heron Therapeutics
HRTX
|
751 | $ 1.26 | 6.3 % | $ 210 M | ||
|
ImmuCell Corporation
ICCC
|
213 | $ 8.28 | -0.84 % | $ 74.7 M | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
Aquestive Therapeutics
AQST
|
-172 | $ 4.14 | 1.47 % | $ 443 M | ||
|
Arcutis Biotherapeutics
ARQT
|
158 | $ 23.57 | 1.33 % | $ 3 B | ||
|
Jaguar Health
JAGX
|
289 | $ 0.36 | -8.39 % | $ 840 K | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
119 | $ 1.46 | 1.04 % | $ 389 M | ||
|
AstraZeneca PLC
AZN
|
-58 | - | - | $ 96.9 B | ||
|
KalVista Pharmaceuticals
KALV
|
-816 | $ 20.08 | 2.29 % | $ 1.08 B | ||
|
BioDelivery Sciences International
BDSI
|
340 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B |